MedSafetyWeek is a global campaign organized by the Iraqi Pharmacovigilance Center in collaboration with the Uppsala Monitoring Centre, alongside more than 100 countries worldwide. It takes place from November 3 to 9 to promote the reporting of adverse drug reactions in Iraq.

The campaign includes various activities on social media and in healthcare institutions to raise awareness about the pharmacovigilance system in Iraq.

The Iraqi Pharmacovigilance Center, part of the Technical Affairs Directorate at the Ministry of Health and as part of the global medicine monitoring program, is responsible for monitoring adverse drug reactions and safety-related issues of medical products in Iraq. It collects, analyzes, and takes action to minimize risks when necessary.